放射性医薬品市場、規模、シェア、動向、産業分析レポート：放射性同位元素タイプ別、用途別、供給源別、エンドユーザー別、地域別-2025年～2034年市場予測

Polaris Market Research社の最新調査によると、放射性医薬品市場規模は2034年までに209億4,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

放射性医薬品市場は、病院や画像診断センターが診断と治療の両面で核医学への依存度を高めていることから、着実に成長しています。これらの特殊な化合物は、PETやSPECTなどの検査で使用され、病態を早期かつ正確に検出します。

現在進行中の研究開発により、より正確で副作用の少ない新しい放射性医薬品の開発が進んでいます。そのため、ヘルスケアプロバイダーは最新の画像診断システムに投資し、核医学部門を拡大しています。このシフトは患者の転帰を改善し、高度な診断・治療サービスを提供しています。

放射性医薬品市場レポートハイライト

放射性同位元素タイプ別では、骨、心臓、腫瘍診断に関連する疾患のSPECTイメージングに広く応用されているテクネチウム99セグメントが2024年の市場を独占しました。

用途別では、神経分野が2024年の市場を独占しました。これは、がんの診断、病期分類、治療計画における放射性医薬品の採用が拡大しているためです。

線源別では、モリブデン-99などのアイソトープが広く使用されているため、原子炉分野が2024年の市場を独占しました。

2024年の世界の放射性医薬品市場では、核医学のインフラ整備が進んでいる北米が大半のシェアを占めています。

アジア太平洋は、インド、中国、韓国のヘルスケアインフラの急速な成長により、かなりの市場シェアを占めています。

世界の主要市場企業には、Advanced Accelerator Applications SA、AstraZeneca plc、Bayer AG、Boehringer Ingelheim International GmbH、Bracco Imaging S.p.A.、Cardinal Health, Inc.、Curium Pharma、Eckert &Ziegler SE、F. Hoffmann-La Roche Ltd.、GE HealthCare Technologies Inc.、GlaxoSmithKline plc（GSK plc）、Jubilant Radiopharma Limited、Lantheus Holdings, Inc.、Eli Lilly and Company、Mallinckrodt plcなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の放射性医薬品市場の洞察

• 市場スナップショット
• 放射性医薬品市場力学
  • 促進要因と機会
    • 世界的にがんと心血管疾患が増加
    • 世界人口の高齢化
  • 抑制要因と課題
    • 高い生産コストと複雑な規制承認
• PESTEL分析
• 放射性医薬品市場の動向
• バリューチェーン分析

第5章 世界の放射性医薬品市場：放射性同位元素タイプ別

• 主な調査結果
• イントロダクション
• テクネチウム99
• フッ素18
• ヨウ素131
• ルテチウム177
• イットリウム90
• ガリウム68
• ガリウム67
• ルビジウム82
• ヨウ素123
• ヨウ素125
• インジウム111
• その他

第6章 世界の放射性医薬品市場：用途別

• 主な調査結果
• イントロダクション
• 腫瘍学
• 心臓病学
• 消化器内科
• 神経内分泌学
• 神経学
• 腎臓学
• その他

第7章 世界の放射性医薬品市場：供給源別展望

• 主な調査結果
• イントロダクション
• 原子炉
• サイクロトロン

第8章 世界の放射性医薬品市場：エンドユーザー別

• 主な調査結果
• イントロダクション
• 病院
• 診断センター
• がん研究機関
• 外来手術センター
• その他

第9章 世界の放射性医薬品市場：地域別

• 主な調査結果
• イントロダクション
  • 放射性医薬品市場評価：地域、2020年～2034年
• 北米
  • 北米：放射性同位元素タイプ別、2020年～2034年
  • 北米：用途別、2020年～2034年
  • 北米：供給源別展望、2020年～2034年
  • 北米：エンドユーザー別、2020年～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：放射性同位元素タイプ別、2020年～2034年
  • 欧州：用途別、2020年～2034年
  • 欧州：供給源別展望、2020年～2034年
  • 欧州：エンドユーザー別、2020年～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋：放射性同位元素タイプ別、2020年～2034年
  • アジア太平洋：用途別、2020年～2034年
  • アジア太平洋：供給源別展望、2020年～2034年
  • アジア太平洋：エンドユーザー別、2020年～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋
• 中東・アフリカ
  • 中東・アフリカ：放射性同位元素タイプ別、2020年～2034年
  • 中東・アフリカ：用途別、2020年～2034年
  • 中東・アフリカ：供給源別展望、2020年～2034年
  • 中東・アフリカ：エンドユーザー別、2020年～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ
• ラテンアメリカ
  • ラテンアメリカ：放射性同位元素タイプ別、2020年～2034年
  • ラテンアメリカ：用途別、2020年～2034年
  • ラテンアメリカ：供給源別展望、2020年～2034年
  • ラテンアメリカ：エンドユーザー別、2020年～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Advanced Accelerator Applications SA
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bracco Imaging S.p.A.
• Cardinal Health, Inc.
• Curium Pharma
• Eckert & Ziegler SE
• F. Hoffmann-La Roche Ltd
• GE HealthCare Technologies Inc.
• GlaxoSmithKline plc（GSK plc）
• Jubilant Radiopharma Limited

List of Tables:

• Table 1 Global Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 2 Global Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 3 Global Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 4 Global Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 5 North America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 6 North America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 7 North America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 8 North America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 9 U.S.: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 10 U.S.: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 11 U.S.: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 12 U.S.: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 13 Canada: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 14 Canada: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 15 Canada: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 16 Canada: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 17 Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 18 Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 19 Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 20 Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 21 UK: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 22 UK: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 23 UK: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 24 UK: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 25 France: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 26 France: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 27 France: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 28 France: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 29 Germany: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 30 Germany: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 31 Germany: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 32 Germany: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 33 Italy: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 34 Italy: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 35 Italy: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 36 Italy: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 37 Spain: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 38 Spain: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 39 Spain: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 40 Spain: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 41 Netherlands: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 42 Netherlands: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 43 Netherlands: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 44 Netherlands: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 45 Russia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 46 Russia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 47 Russia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 48 Russia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 57 China: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 58 China: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 59 China: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 60 China: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 61 India: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 62 India: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 63 India: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 64 India: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 65 Malaysia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 66 Malaysia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 67 Malaysia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 68 Malaysia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 69 Japan: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 70 Japan: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 71 Japan: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 72 Japan: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 73 Indonesia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 74 Indonesia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 75 Indonesia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 76 Indonesia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 77 South Korea: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 78 South Korea: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 79 South Korea: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 80 South Korea: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 81 Australia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 82 Australia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 83 Australia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 84 Australia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 97 UAE: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 98 UAE: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 99 UAE: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 100 UAE: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 101 Israel: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 102 Israel: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 103 Israel: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 104 Israel: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 105 South Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 106 South Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 107 South Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 108 South Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 113 Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 114 Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 115 Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 116 Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 117 Mexico: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 118 Mexico: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 119 Mexico: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 120 Mexico: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 121 Brazil: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 122 Brazil: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 123 Brazil: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 124 Brazil: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 125 Argentina: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 126 Argentina: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 127 Argentina: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 128 Argentina: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Global Radiopharmaceuticals Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Radioisotope Type
• Figure 7. Global Radiopharmaceuticals Market, by Radioisotope Type, 2024 & 2034 (USD Billion)
• Figure 8. Market by Application
• Figure 9. Global Radiopharmaceuticals Market, by Application, 2024 & 2034 (USD Billion)
• Figure 10. Market by Source Outlook
• Figure 11. Global Radiopharmaceuticals Market, by Source Outlook, 2024 & 2034 (USD Billion)
• Figure 12. Market by End User
• Figure 13. Global Radiopharmaceuticals Market, by End User, 2024 & 2034 (USD Billion)

The radiopharmaceuticals market size is expected to reach USD 20.94 Billion by 2034, according to a new study by Polaris Market Research. The report "Radiopharmaceuticals Market Size, Share, Trends, & Industry Analysis Report By Radioisotope Type (Technetium-99, Fluorine-18), By Application, By Source, By End User, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The radiopharmaceuticals market is growing steadily as hospitals and imaging centers increasingly rely on nuclear medicine for both diagnosis and treatment. These specialized compounds are used in scans such as PET and SPECT to detect conditions early and accurately.

Ongoing research is leading to the development of new radiopharmaceuticals that are more precise and contains fewer side effects. Therefore, healthcare providers are investing in modern imaging systems and expanding nuclear medicine departments. This shift is improving patient outcomes, providing advanced diagnostic and therapeutic services.

Radiopharmaceuticals Market Report Highlights

Based on radioisotope type, the technetium-99 segment dominated the market in 2024, due to its widespread application in SPECT imaging for conditions related to bone, cardiac, and oncology diagnostics.

In terms of application, the neurology segment dominated the market in 2024. This is owing the growing adoption of radiopharmaceuticals in cancer diagnosis, staging, and treatment planning.

In terms of source, the nuclear reactors segment dominated the market in 2024, due to the extensive use of isotopes such as molybdenum-99.

North America accounted for the majority share in the global Radiopharmaceuticals market in 2024, due to advanced nuclear medicine infrastructure.

Asia Pacific held substantial market share, owing to rapid growth in healthcare infrastructure across India, China, and South Korea.

A few global key market players include Advanced Accelerator Applications SA, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bracco Imaging S.p.A., Cardinal Health, Inc., Curium Pharma, Eckert & Ziegler SE, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., GlaxoSmithKline plc (GSK plc), Jubilant Radiopharma Limited, Lantheus Holdings, Inc., Eli Lilly and Company, and Mallinckrodt plc.

Polaris Market Research has segmented the market report on the basis of type, application, source, end user, and region:

By Radioisotope Type Outlook (Revenue, USD Billion, 2020-2034)

Technetium-99

Fluorine-18

Iodine-131

Lutetium-177

Yttrium-90

Gallium-68

Gallium-67

Rubidium-82

Iodine-123

Iodine-125

Indium-111

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Cardiology

Gastroenterology

Neuroendocrinology

Neurology

Nephrology

Others

By Source Outlook (Revenue, USD Billion, 2020-2034)

Nuclear Reactors

Cyclotrons

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Diagnostic Centers

Cancer Research Institutes

Ambulatory Surgical Centers

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Radiopharmaceuticals Market Insights

• 4.1. Radiopharmaceuticals Market - Market Snapshot
• 4.2. Radiopharmaceuticals Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Number of Cancer and Cardiovascular Diseases Globally
    • 4.2.1.2. Aging Global Population
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Production Costs and Complex Regulatory Approvals
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Radiopharmaceuticals Market Trends
• 4.6. Value Chain Analysis

5. Global Radiopharmaceuticals Market, by Radioisotope Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
• 5.3. Technetium-99
  • 5.3.1. Global Radiopharmaceuticals Market, by Technetium-99, by Region, 2020-2034 (USD Billion)
• 5.4. Fluorine-18
  • 5.4.1. Global Radiopharmaceuticals Market, by Fluorine-18, by Region, 2020-2034 (USD Billion)
• 5.5. Iodine-131
  • 5.5.1. Global Radiopharmaceuticals Market, by Iodine-131, by Region, 2020-2034 (USD Billion)
• 5.6. Lutetium-177
  • 5.6.1. Global Radiopharmaceuticals Market, by Lutetium-177, by Region, 2020-2034 (USD Billion)
• 5.7. Yttrium-90
  • 5.7.1. Global Radiopharmaceuticals Market, by Yttrium-90, by Region, 2020-2034 (USD Billion)
• 5.8. Gallium-68
  • 5.8.1. Global Radiopharmaceuticals Market, by Gallium-68, by Region, 2020-2034 (USD Billion)
• 5.9. Gallium-67
  • 5.9.1. Global Radiopharmaceuticals Market, by Gallium-67, by Region, 2020-2034 (USD Billion)
• 5.10. Rubidium-82
  • 5.10.1. Global Radiopharmaceuticals Market, by Rubidium-82, by Region, 2020-2034 (USD Billion)
• 5.11. Iodine-123
  • 5.11.1. Global Radiopharmaceuticals Market, by Iodine-123, by Region, 2020-2034 (USD Billion)
• 5.12. Iodine-125
  • 5.12.1. Global Radiopharmaceuticals Market, by Iodine-125, by Region, 2020-2034 (USD Billion)
• 5.13. Indium-111
  • 5.13.1. Global Radiopharmaceuticals Market, by Indium-111, by Region, 2020-2034 (USD Billion)
• 5.14. Others
  • 5.14.1. Global Radiopharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Radiopharmaceuticals Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
• 6.3. Oncology
  • 6.3.1. Global Radiopharmaceuticals Market, by Oncology, by Region, 2020-2034 (USD Billion)
• 6.4. Cardiology
  • 6.4.1. Global Radiopharmaceuticals Market, by Cardiology, by Region, 2020-2034 (USD Billion)
• 6.5. Gastroenterology
  • 6.5.1. Global Radiopharmaceuticals Market, by Gastroenterology, by Region, 2020-2034 (USD Billion)
• 6.6. Neuroendocrinology
  • 6.6.1. Global Radiopharmaceuticals Market, by Neuroendocrinology, by Region, 2020-2034 (USD Billion)
• 6.7. Neurology
  • 6.7.1. Global Radiopharmaceuticals Market, by Neurology, by Region, 2020-2034 (USD Billion)
• 6.8. Nephrology
  • 6.8.1. Global Radiopharmaceuticals Market, by Nephrology, by Region, 2020-2034 (USD Billion)
• 6.9. Others
  • 6.9.1. Global Radiopharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Radiopharmaceuticals Market, by Source Outlook

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
• 7.3. Nuclear Reactors
  • 7.3.1. Global Radiopharmaceuticals Market, by Nuclear Reactors, by Region, 2020-2034 (USD Billion)
• 7.4. Cyclotrons
  • 7.4.1. Global Radiopharmaceuticals Market, by Cyclotrons, by Region, 2020-2034 (USD Billion)

8. Global Radiopharmaceuticals Market, by End User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• 8.3. Hospitals
  • 8.3.1. Global Radiopharmaceuticals Market, by Hospitals, by Region, 2020-2034 (USD Billion)
• 8.4. Diagnostic Centers
  • 8.4.1. Global Radiopharmaceuticals Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
• 8.5. Cancer Research Institutes
  • 8.5.1. Global Radiopharmaceuticals Market, by Cancer Research Institutes, by Region, 2020-2034 (USD Billion)
• 8.6. Ambulatory Surgical Centers
  • 8.6.1. Global Radiopharmaceuticals Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
• 8.7. Others
  • 8.7.1. Global Radiopharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Radiopharmaceuticals Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Radiopharmaceuticals Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Radiopharmaceuticals Market - North America
  • 9.3.1. North America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • 9.3.2. North America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • 9.3.3. North America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • 9.3.4. North America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.3.5. Radiopharmaceuticals Market - U.S.
    • 9.3.5.1. U.S.: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.3.5.2. U.S.: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5.3. U.S.: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.3.5.4. U.S.: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.3.6. Radiopharmaceuticals Market - Canada
    • 9.3.6.1. Canada: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• 9.4. Radiopharmaceuticals Market - Europe
  • 9.4.1. Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.4.5. Radiopharmaceuticals Market - UK
    • 9.4.5.1. UK: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.4.6. Radiopharmaceuticals Market - France
    • 9.4.6.1. France: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.4.7. Radiopharmaceuticals Market - Germany
    • 9.4.7.1. Germany: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.4.8. Radiopharmaceuticals Market - Italy
    • 9.4.8.1. Italy: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.4.9. Radiopharmaceuticals Market - Spain
    • 9.4.9.1. Spain: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.4.10. Radiopharmaceuticals Market - Netherlands
    • 9.4.10.1. Netherlands: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.4.11. Radiopharmaceuticals Market - Russia
    • 9.4.11.1. Russia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.4.12. Radiopharmaceuticals Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• 9.5. Radiopharmaceuticals Market - Asia Pacific
  • 9.5.1. Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.5.5. Radiopharmaceuticals Market - China
    • 9.5.5.1. China: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.5.6. Radiopharmaceuticals Market - India
    • 9.5.6.1. India: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.5.7. Radiopharmaceuticals Market - Malaysia
    • 9.5.7.1. Malaysia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.5.8. Radiopharmaceuticals Market - Japan
    • 9.5.8.1. Japan: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.5.9. Radiopharmaceuticals Market - Indonesia
    • 9.5.9.1. Indonesia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.5.10. Radiopharmaceuticals Market - South Korea
    • 9.5.10.1. South Korea: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.5.11. Radiopharmaceuticals Market - Australia
    • 9.5.11.1. Australia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.5.12. Radiopharmaceuticals Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• 9.6. Radiopharmaceuticals Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.6.5. Radiopharmaceuticals Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.6.6. Radiopharmaceuticals Market - UAE
    • 9.6.6.1. UAE: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.6.7. Radiopharmaceuticals Market - Israel
    • 9.6.7.1. Israel: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.6.8. Radiopharmaceuticals Market - South Africa
    • 9.6.8.1. South Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.6.9. Radiopharmaceuticals Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
• 9.7. Radiopharmaceuticals Market - Latin America
  • 9.7.1. Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.7.5. Radiopharmaceuticals Market - Mexico
    • 9.7.5.1. Mexico: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.7.6. Radiopharmaceuticals Market - Brazil
    • 9.7.6.1. Brazil: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.7.7. Radiopharmaceuticals Market - Argentina
    • 9.7.7.1. Argentina: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.7.8. Radiopharmaceuticals Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Advanced Accelerator Applications SA
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. AstraZeneca plc
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Bayer AG
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Boehringer Ingelheim International GmbH
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Bracco Imaging S.p.A.
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Cardinal Health, Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Curium Pharma
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Eckert & Ziegler SE
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. F. Hoffmann-La Roche Ltd
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. GE HealthCare Technologies Inc.
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. GlaxoSmithKline plc (GSK plc)
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Jubilant Radiopharma Limited
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development